- This Week in Managed Care: September 13, 2019 (ajmc.com)
Laura Joszt, Managing Editor at The American Journal of Managed Care. Welcome to This Week in Managed Care from the Managed Markets News Network
- This Week in Managed Care: September 6, 2019 (ajmc.com)
Laura Joszt, Managing Editor at The American Journal of Managed Care. Welcome to This Week in Managed Care from the Managed Markets News Network
- August 30 Pharmacy Week in Review: Family History of Diabetes Linked to Increased Bone Mineral Density; Moderate Exercise May Benefit Patients with Metastatic Colon Cancer (pharmacytimes.com)
Nicole Grassano, PTNN, Pharmacy Week in Review, this weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
- This Week in Managed Care: August 23, 2019 (ajmc.com)This Week in Managed Care: August 16, 2019 (ajmc.com)
Laura Joszt, Managing Editor at The American Journal of Managed Care. Welcome to This Week in Managed Care from the Managed Markets News Network
- September 13 Pharmacy Week in Review: WHO Statement Emphasizes Accurate Vaccine Information; FDA Issues Warning Letter to JUUL Labs; Study Says Many Deaths Still Attributed HIV (pharmacytimes.com)
Laura Joszt, PTNN, Pharmacy Week in Review, this weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
- September 6 Pharmacy Week in Review: Study Links Tramadol to Increased Risk of Hypoglycemia; Pinterest Supporting Reliable Vaccine Health Information (pharmacytimes.com)
Nicole Grassano, PTNN, Pharmacy Week in Review, this weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
- DEA to expand marijuana research after years of delay (reuters.com)
The U.S. Drug Enforcement Administration said...that it will move ahead with a long-delayed expansion of its marijuana research program, in a sign that the Trump administration’s hostility to the drug may be waning as a growing number of states have legalized its use...The DEA said it would roll out new guidelines that would allow more growers to produce marijuana for scientific and medical research…READ MORE
- Cannabidiol Products’ Impact on Pharmacist-Provided Medication Management (pharmacytimes.com)
With greater patient access to CBD, pharmacists will need to be prepared to address potential drug interactions to help patients use these products safely. The FDA has issued numerous warning letters instructing various manufacturers to halt production of OTC CBD products since 2016...Regarding interactions, in vitro studies have illustrated multiple potential drug interactions for CBD. The lack of standardized products somewhat limits the ability to make definitive statements from available research, but there is evidence that CBD is an inhibitor of many CYP450 enzymes including 2D6, 3A4, and 3A5, as well as a potent p-glycoprotein inhibitor...Research also suggests CBD use enhances the effect of opiates, and exhibits other interactions with barbiturates, fluoxetine, sedatives, and antihistamines, as well as having synergistic effects with alcohol...READ MORE
- This Week in Managed Care: August 30, 2019 (ajmc.com)
Laura Joszt, Managing Editor at The American Journal of Managed Care. Welcome to This Week in Managed Care from the Managed Markets News Network
- Florida connects to Military Health System PDMP to bolster opioid response (fiercehealthcare.com)
The state of Florida is partnering with the Military Health System to share prescription drug data to help providers in the state combat the risk of prescription drug misuse and abuse among the military population...the MHS prescription drug monitoring program began sharing the prescription drug data and analytics with 39 databases throughout the U.S., with the goal of enabling data-sharing among all 54 PDMPs across the country...Healthcare providers in Florida now have access to controlled substance prescription data from military health providers and facilities...READ MORE